ARIX.L Regulatory News (ARIX)

ARIX.L Information

There is currently no data for ARIX

Holding(s) in Company

24 Jan 2024 17:30

Arix Bioscience PLC (ARIX) Holding(s) in Company 24-Jan-2024 / 17:30 GMT/BST

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDO45071

Issuer Name

Arix Bioscience plc

UK or Non-UK Issuer

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Acacia Research Corporation

City of registered office (if applicable)

Country of registered office (if applicable)

4. Details of the shareholder

Name	City of registered office	Country of registered office
Merton Acquisition Holdco LLC	New York	United States

5. Date on which the threshold was crossed or reached

19-Jan-2024

6. Date on which Issuer notified

24-Jan-2024

7. Total positions of person(s) subject to the notification obligation

.	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	0.000000	0.000000	0.000000	0
Position of previous notification (if applicable)	25.563559	0.000000	25.563559

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BD045071	0		0.000000
Sub Total 8.A	0		0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Acacia Research Corporation	Merton Acquisition Holdco LLC	0.000000		0.000000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Merton Acquisition Holdco LLC is a wholly owned subsidiary of Acacia Research Corporation.

12. Date of Completion

24-Jan-2024

13. Place Of Completion

New York, New York, USA

Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


ISIN:	GB00BD045071
Category Code:	HOL
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	2.3. Major shareholding notifications
Sequence No.:	299503
EQS News ID:	1822383


End of Announcement	EQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date		Source	Headline
29th Jul 2021	5:30 pm	EQS	Transaction in own shares
28th Jul 2021	5:30 pm	EQS	Transaction in own shares
27th Jul 2021	5:05 pm	EQS	Transaction in own shares
27th Jul 2021	7:02 am	EQS	Artios raises $153m in Series C financing
26th Jul 2021	5:00 pm	EQS	Transaction in own shares
23rd Jul 2021	5:05 pm	EQS	Transaction in own shares
22nd Jul 2021	5:07 pm	EQS	Transaction in own shares
21st Jul 2021	5:19 pm	EQS	Transaction in own shares
21st Jul 2021	7:00 am	EQS	Notice of Results
20th Jul 2021	5:14 pm	EQS	Transaction in own shares
19th Jul 2021	5:19 pm	EQS	Transaction in own shares
16th Jul 2021	5:20 pm	EQS	Transaction in own shares
15th Jul 2021	5:19 pm	EQS	Transaction in own shares
14th Jul 2021	5:08 pm	EQS	Transaction in own shares
14th Jul 2021	9:00 am	EQS	Imara announces pricing of public offering
14th Jul 2021	7:00 am	EQS	Transaction in own shares
12th Jul 2021	5:33 pm	EQS	Transaction in own shares
8th Jul 2021	5:15 pm	EQS	Transaction in own shares
7th Jul 2021	5:37 pm	EQS	Transaction in own shares
6th Jul 2021	5:26 pm	EQS	Transaction in own shares
6th Jul 2021	7:01 am	EQS	Team changes
5th Jul 2021	4:59 pm	EQS	Transaction in own shares
1st Jul 2021	5:09 pm	EQS	Transaction in own shares
1st Jul 2021	7:01 am	EQS	Total Voting Rights
30th Jun 2021	5:00 pm	EQS	Transaction in own shares
29th Jun 2021	4:54 pm	EQS	Transaction in own shares
28th Jun 2021	5:38 pm	EQS	Transaction in own shares
25th Jun 2021	4:57 pm	EQS	Transaction in own shares
24th Jun 2021	5:21 pm	EQS	Transaction in own shares
23rd Jun 2021	5:06 pm	EQS	Transaction in own shares
22nd Jun 2021	5:18 pm	EQS	Transaction in own shares
21st Jun 2021	5:06 pm	EQS	Transaction in own shares
18th Jun 2021	5:13 pm	EQS	Transaction in own shares
17th Jun 2021	5:12 pm	EQS	Transaction in own shares
16th Jun 2021	5:25 pm	EQS	Transaction in own shares
15th Jun 2021	5:40 pm	EQS	Transaction in own shares
14th Jun 2021	5:20 pm	EQS	Transaction in own shares
14th Jun 2021	2:55 pm	EQS	Results of Annual General Meeting
11th Jun 2021	5:01 pm	EQS	Transaction in own shares
11th Jun 2021	1:05 pm	EQS	Clinical portfolio update
10th Jun 2021	5:26 pm	EQS	Transaction in own shares
9th Jun 2021	5:15 pm	EQS	Transaction in own shares
8th Jun 2021	5:14 pm	EQS	Transaction in own shares
7th Jun 2021	5:08 pm	EQS	Transaction in own shares
4th Jun 2021	5:13 pm	EQS	Transaction in own shares
4th Jun 2021	3:25 pm	EQS	Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting
3rd Jun 2021	5:34 pm	EQS	Transaction in own shares
2nd Jun 2021	5:12 pm	EQS	Transaction in own shares
1st Jun 2021	5:35 pm	EQS	Transaction in own shares
1st Jun 2021	7:01 am	EQS	Total Voting Rights

Latest Share Chat

ARIX.L Regulatory News (ARIX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

Login to your account

Quickpicks are a member only feature

Login to your account